Percutaneous treatment of mitral regurgitation in patients with impaired ventricular function: Impact of intracardiac electronic devices (from the German Transcatheter Mitral Valve Interventions Registry).
Giuseppe D'AnconaHüseyin InceWolfgang SchillingerJochen SengesTaoufik OuarrakChristian ButterMartin SeifertThomas SchauEdith LubosPeter BoekstegersRalph Stephan von BardelebenErdal SafakPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
A third of patients have been already submitted to CEDs implantation at time of referral for MC therapy and 40% of those with severely depressed LVEF% arrive to MC therapy before ICD/CRT implantation. The presence of CED does not impair acute MC therapy success. Mid-term follow-up outcomes are similar in patients with and without CEDs.
Keyphrases
- mitral valve
- end stage renal disease
- heart failure
- primary care
- newly diagnosed
- ejection fraction
- chronic kidney disease
- minimally invasive
- liver failure
- stem cells
- prognostic factors
- intensive care unit
- peritoneal dialysis
- physical activity
- adipose tissue
- replacement therapy
- acute respiratory distress syndrome
- atrial fibrillation
- cardiac resynchronization therapy
- smoking cessation
- weight loss